Simulations Plus, Inc. (SLP)
USD 24.41
(-4.96%)
USD 24.41
(-4.96%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 | 6.13 Million USD | -6.12% |
| 2023 | 12.56 Million USD | -41.49% |
| 2022 | 18.48 Million USD | 30.18% |
| 2021 | 14.69 Million USD | -3.36% |
| 2020 | 11.85 Million USD | -11.76% |
| 2019 | 13.3 Million USD | 2.96% |
| 2018 | 11.71 Million USD | 25.26% |
| 2017 | 10.37 Million USD | 13.49% |
| 2016 | 9.16 Million USD | 51.99% |
| 2015 | 7.68 Million USD | 37.33% |
| 2014 | 5.47 Million USD | -10.71% |
| 2013 | 4.83 Million USD | 11.5% |
| 2012 | 4.67 Million USD | -0.52% |
| 2011 | 4.51 Million USD | 21.46% |
| 2010 | 3.78 Million USD | 48.18% |
| 2009 | 2.58 Million USD | -6.52% |
| 2008 | 2.72 Million USD | -12.27% |
| 2007 | 3.01 Million USD | 158.83% |
| 2006 | 1.19 Million USD | 135.05% |
| 2005 | 503.31 Thousand USD | -41.85% |
| 2004 | 850.2 Thousand USD | -41.9% |
| 2003 | 1.46 Million USD | 111.48% |
| 2002 | 691.94 Thousand USD | 652.91% |
| 2001 | 91.9 Thousand USD | 319.97% |
| 2000 | 24.48 Thousand USD | 106.16% |
| 1999 | -205.28 Thousand USD | 78.17% |
| 1998 | -1.7 Million USD | -112.3% |
| 1997 | -1.02 Million USD | -866.58% |
| 1996 | 100 Thousand USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 960 Thousand USD | 85.44% |
| 2024 Q3 | 3.14 Million USD | -43.34% |
| 2024 Q4 | 9 Million USD | -66.43% |
| 2024 Q2 | 5.54 Million USD | 170.45% |
| 2023 Q4 | -284 Thousand USD | -106.93% |
| 2023 Q1 | 878 Thousand USD | 27.62% |
| 2023 FY | - USD | -41.49% |
| 2023 Q2 | 4.03 Million USD | 359.45% |
| 2023 Q3 | 4.09 Million USD | 1.56% |
| 2022 Q1 | 3.79 Million USD | 1630.59% |
| 2022 FY | - USD | 30.18% |
| 2022 Q4 | 688 Thousand USD | -86.09% |
| 2022 Q3 | 4.94 Million USD | -9.74% |
| 2022 Q2 | 5.48 Million USD | 44.59% |
| 2021 Q4 | 219 Thousand USD | -95.22% |
| 2021 Q1 | 4.03 Million USD | 69.99% |
| 2021 Q3 | 4.57 Million USD | 29.2% |
| 2021 Q2 | 3.54 Million USD | -12.1% |
| 2021 FY | - USD | -3.36% |
| 2020 Q4 | 2.37 Million USD | -48.99% |
| 2020 FY | - USD | -11.76% |
| 2020 Q1 | 3.4 Million USD | 76.55% |
| 2020 Q2 | 2.83 Million USD | -16.54% |
| 2020 Q3 | 4.64 Million USD | 63.84% |
| 2019 Q1 | 2.09 Million USD | -20.01% |
| 2019 Q2 | 2.73 Million USD | 30.87% |
| 2019 Q3 | 4.57 Million USD | 67.08% |
| 2019 Q4 | 1.92 Million USD | -57.86% |
| 2019 FY | - USD | 2.96% |
| 2018 Q4 | 2.61 Million USD | -36.46% |
| 2018 Q2 | 2.42 Million USD | -24.43% |
| 2018 FY | - USD | 25.26% |
| 2018 Q1 | 3.2 Million USD | 56.0% |
| 2018 Q3 | 4.11 Million USD | 69.73% |
| 2017 Q3 | 3.62 Million USD | 55.76% |
| 2017 Q2 | 2.32 Million USD | -3.41% |
| 2017 Q1 | 2.4 Million USD | 64.96% |
| 2017 FY | - USD | 13.49% |
| 2017 Q4 | 2.05 Million USD | -43.28% |
| 2016 FY | - USD | 51.99% |
| 2016 Q1 | 2.22 Million USD | 60.6% |
| 2016 Q2 | 1.74 Million USD | -21.74% |
| 2016 Q4 | 1.46 Million USD | -55.2% |
| 2016 Q3 | 3.25 Million USD | 86.9% |
| 2015 Q2 | 1.5 Million USD | 99.4% |
| 2015 Q1 | 757.16 Thousand USD | 27.55% |
| 2015 FY | - USD | 37.33% |
| 2015 Q3 | 3.39 Million USD | 124.74% |
| 2015 Q4 | 1.38 Million USD | -59.1% |
| 2014 Q3 | 2.08 Million USD | 56.19% |
| 2014 FY | - USD | -10.71% |
| 2014 Q1 | 935.66 Thousand USD | 113.54% |
| 2014 Q2 | 1.33 Million USD | 42.46% |
| 2014 Q4 | 593.64 Thousand USD | -71.49% |
| 2013 Q3 | 1.73 Million USD | -0.36% |
| 2013 FY | - USD | 11.5% |
| 2013 Q1 | 1 Million USD | 96.49% |
| 2013 Q2 | 1.73 Million USD | 73.81% |
| 2013 Q4 | 438.17 Thousand USD | -74.7% |
| 2012 Q3 | 1.42 Million USD | -7.45% |
| 2012 FY | - USD | -0.52% |
| 2012 Q1 | 974.44 Thousand USD | 14.51% |
| 2012 Q2 | 1.53 Million USD | 57.53% |
| 2012 Q4 | 509.03 Thousand USD | -64.17% |
| 2011 Q1 | 1.02 Million USD | 91.47% |
| 2011 Q3 | 1.34 Million USD | -13.81% |
| 2011 Q2 | 1.55 Million USD | 52.81% |
| 2011 Q4 | 850.94 Thousand USD | -36.68% |
| 2011 FY | - USD | 21.46% |
| 2010 FY | - USD | 48.18% |
| 2010 Q4 | 532.9 Thousand USD | -57.91% |
| 2010 Q3 | 1.26 Million USD | 14.24% |
| 2010 Q2 | 1.1 Million USD | 48.2% |
| 2010 Q1 | 747.81 Thousand USD | 232.94% |
| 2009 Q1 | 525.53 Thousand USD | 660.87% |
| 2009 Q4 | 224.6 Thousand USD | -77.7% |
| 2009 Q3 | 1 Million USD | 66.17% |
| 2009 FY | - USD | -6.52% |
| 2009 Q2 | 606.11 Thousand USD | 15.33% |
| 2008 FY | - USD | -12.27% |
| 2008 Q4 | 69.07 Thousand USD | -94.87% |
| 2008 Q3 | 1.34 Million USD | 75.7% |
| 2008 Q2 | 765.61 Thousand USD | -39.89% |
| 2008 Q1 | 1.27 Million USD | 66.56% |
| 2007 Q2 | 953.36 Thousand USD | 380.19% |
| 2007 Q3 | 1.09 Million USD | 14.46% |
| 2007 Q4 | 764.69 Thousand USD | -29.92% |
| 2007 FY | - USD | 158.83% |
| 2007 Q1 | 198.53 Thousand USD | -54.35% |
| 2006 Q1 | -175.93 Thousand USD | -229.25% |
| 2006 FY | - USD | 135.05% |
| 2006 Q3 | 529.68 Thousand USD | 41.85% |
| 2006 Q2 | 373.41 Thousand USD | 312.24% |
| 2006 Q4 | 434.9 Thousand USD | -17.89% |
| 2005 Q4 | 136.12 Thousand USD | -50.18% |
| 2005 FY | - USD | -41.85% |
| 2005 Q2 | 51.07 Thousand USD | 50.38% |
| 2005 Q3 | 273.21 Thousand USD | 434.95% |
| 2005 Q1 | 33.96 Thousand USD | -93.37% |
| 2004 Q1 | 98.38 Thousand USD | -88.8% |
| 2004 Q4 | 512.34 Thousand USD | 241.06% |
| 2004 Q3 | 150.22 Thousand USD | 68.22% |
| 2004 Q2 | 89.3 Thousand USD | -9.23% |
| 2004 FY | - USD | -41.9% |
| 2003 Q2 | 116.67 Thousand USD | -34.35% |
| 2003 Q1 | 177.72 Thousand USD | -10.09% |
| 2003 Q3 | 285.37 Thousand USD | 146.58% |
| 2003 Q4 | 878.36 Thousand USD | 205.32% |
| 2003 FY | - USD | 111.48% |
| 2002 Q4 | 197.67 Thousand USD | 25.64% |
| 2002 FY | - USD | 652.91% |
| 2002 Q3 | 157.33 Thousand USD | -42.89% |
| 2002 Q2 | 275.51 Thousand USD | 348.56% |
| 2002 Q1 | 61.42 Thousand USD | 133.24% |
| 2001 FY | - USD | 319.97% |
| 2001 Q4 | -184.75 Thousand USD | -1003.01% |
| 2001 Q3 | 20.46 Thousand USD | -87.67% |
| 2001 Q2 | 165.88 Thousand USD | 185.52% |
| 2001 Q1 | 58.09 Thousand USD | 962.61% |
| 2000 FY | - USD | 106.16% |
| 2000 Q1 | 8844.00 USD | -98.38% |
| 2000 Q4 | -5960.00 USD | 91.67% |
| 2000 Q3 | -80.85 Thousand USD | -180.35% |
| 2000 Q2 | 100.02 Thousand USD | 1037.8% |
| 1999 Q2 | -200 Thousand USD | -100.0% |
| 1999 Q1 | -100 Thousand USD | -136.69% |
| 1999 FY | - USD | 78.17% |
| 1999 Q3 | -100 Thousand USD | 50.0% |
| 1999 Q4 | 494.71 Thousand USD | 644.72% |
| 1998 Q2 | -500 Thousand USD | 0.0% |
| 1998 FY | - USD | -112.3% |
| 1998 Q3 | -500 Thousand USD | 0.0% |
| 1998 Q4 | 147.61 Thousand USD | 154.51% |
| 1998 Q1 | -500 Thousand USD | -200.15% |
| 1997 FY | - USD | -866.58% |
| 1997 Q3 | -200 Thousand USD | 0.0% |
| 1997 Q2 | -100 Thousand USD | -116.67% |
| 1997 Q4 | -229.42 Thousand USD | -66.58% |
| 1997 Q1 | 600 Thousand USD | 0.0% |
| 1996 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| CareCloud, Inc. | -31.29 Million USD | 119.594% |
| Augmedix, Inc. | -17.68 Million USD | 134.676% |
| BrightSpring Health Services, Inc. Common Stock | 349.51 Million USD | 98.246% |
| CareCloud, Inc. | -31.29 Million USD | 119.594% |
| HealthEquity, Inc. | 282.41 Million USD | 97.829% |
| iCoreConnect Inc. | -11.87 Million USD | 151.61% |
| Inovalon Holdings, Inc. | 186.56 Million USD | 96.714% |
| Nutex Health, Inc. | -14.58 Million USD | 142.047% |
| Omnicell, Inc. | 60.69 Million USD | 89.898% |
| OneMedNet Corporation | -11.97 Million USD | 151.216% |
| Progyny, Inc. | 64.46 Million USD | 90.489% |
| Renalytix Plc | -28.52 Million USD | 121.496% |
| Schrödinger, Inc. | -171.89 Million USD | 103.567% |
| SOPHiA GENETICS SA | -70.7 Million USD | 108.672% |
| Streamline Health Solutions, Inc. | -12.81 Million USD | 147.839% |
| Ontrak, Inc. | -14.41 Million USD | 142.529% |
| GE HealthCare Technologies Inc. | 3.56 Billion USD | 99.828% |
| Sharecare, Inc. | -67.25 Million USD | 109.116% |
| Aclarion, Inc. | -4.14 Million USD | 248.077% |
| CareMax, Inc. | -590.46 Million USD | 101.038% |
| Bullfrog AI Holdings, Inc. Common Stock | -5.27 Million USD | 216.226% |
| Forian Inc. | 2.75 Million USD | -122.922% |
| Bullfrog AI Holdings, Inc. Warrants | -5.27 Million USD | 216.226% |
| HeartBeam, Inc. | 675 Thousand USD | -808.296% |
| GeneDx Holdings Corp. | -136.46 Million USD | 104.493% |
| SCWorx Corp. | -3.97 Million USD | 254.251% |
| Minerva Surgical, Inc. | -20.07 Million USD | 130.544% |
| Definitive Healthcare Corp. | -241.22 Million USD | 102.542% |
| 10x Genomics, Inc. | -205.11 Million USD | 102.989% |
| Zhongchao Inc. | -4.9 Million USD | 225.062% |
| Accolade, Inc. | -71.19 Million USD | 108.612% |
| MSP Recovery, Inc. | -69.22 Million USD | 108.857% |
| R1 RCM Inc. | 426.2 Million USD | 98.561% |
| Spok Holdings, Inc. | 26.29 Million USD | 76.686% |
| Privia Health Group, Inc. | 27.18 Million USD | 77.445% |
| EUDA Health Holdings Limited | -8.3 Million USD | 173.864% |
| TruBridge, Inc. | -15.39 Million USD | 139.835% |
| BrightSpring Health Services, Inc. Tangible Equity Unit | 349.51 Million USD | 98.246% |
| Sharecare, Inc. | -67.25 Million USD | 109.116% |
| Health Catalyst, Inc. | -66.46 Million USD | 109.225% |
| GoodRx Holdings, Inc. | 108.82 Million USD | 94.366% |
| Premier, Inc. | 286.08 Million USD | 97.857% |
| HealthStream, Inc. | 59.58 Million USD | 89.711% |
| Certara, Inc. | 23.84 Million USD | 74.287% |
| GeneDx Holdings Corp. | -136.46 Million USD | 104.493% |
| Ontrak, Inc. | -14.41 Million USD | 142.529% |
| SHL Telemedicine Ltd. | 3.28 Million USD | -86.721% |
| CareCloud, Inc. | -31.29 Million USD | 119.594% |
| EUDA Health Holdings Limited | -8.3 Million USD | 173.864% |
| HeartBeam, Inc. | 675 Thousand USD | -808.296% |
| Mangoceuticals, Inc. | -9.18 Million USD | 166.732% |
| CareMax, Inc. | -590.46 Million USD | 101.038% |
| Healthcare Triangle, Inc. | -4.1 Million USD | 249.391% |
| National Research Corporation | 45.98 Million USD | 86.667% |
| Aclarion, Inc. | -4.14 Million USD | 248.077% |
| OptimizeRx Corporation | -21.3 Million USD | 128.773% |